Keywords: symphony, selects, stroke, compound, pharmaceuticals, selected, its

Symphony Selects Stroke Compound

Article | 19 February 1996

Symphony Pharmaceuticals has selected its lead compound for the treatment of stroke and epilepsy, SYM 2206, from its portfolio of molecules ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in